Scientific Vita


Steeve Boulant

Scholarships / Awards / Honors
1998 - 2000
Bachelor degree in Molecular Biology and Biochemistry, Lyon, France
1996 - 1998
Classe préparatoire Mathematic superior, Lycée Ozenne, Toulouse, France

Advanced academic qualifications
2001 - 2004
Ph.D. in Molecular Biology and Biochemistry, IBCP-CNRS, France

Postgraduate professional career
From 01/2020
Heisenberg Fellow from the DFG (German research foundation)
2012 - 2019
Junior Group Leader CHS Foundation, University Hospital Heidelberg
2008 - 2012
Post doctoral associate, Harvard Medical School Boston MA, USA
2006 - 2008
Marie Curie post doctoral fellow, MRC Virology Unit Glasgow, UK
2005 - 2006
Post doctoral associate, MRC Virology Unit Glasgow, UK
2004 - 2005
Bridging grant fellow, IBCP-CNRS Lyon, France
Muenchau S, Deutsch R, de Castro IJ, Hielscher T, Heber N, Niesler B, Lusic M, Stanifer ML, Boulant S. 2019. Hypoxic environment promotes barrier formation in human intestinal epithelial cells through regulation of miRNA-320a expression. Mol Cell Biol. pii: MCB.00553-18. doi: 10.1128/MCB.00553-18.
Pervolaraki K, Rastgou Talemi S, Albrecht D, Bormann F, Bamford C, Mendoza JL, Garcia KC, McLauchlan J, Höfer T, Stanifer ML, Boulant S. 2018. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. PLoS Pathog. 14(11):e1007420.
Fratini M, Wiegand T, Funaya C, Jiang Z, Shah PNM, Spatz JP, Cavalcanti-Adam EA, Boulant S. 2018. Surface Immobilization of Viruses and Nanoparticles Elucidates Early Events in Clathrin-Mediated Endocytosis. ACS Infect Dis. 4(11):1585-1600.
Bucher D, Frey F, Sochacki KA, Kummer S, Bergeest JP, Godinez WJ, Kräusslich HG, Rohr K, Taraska JW, Schwarz US, Boulant S. 2018. Clathrin-adaptor ratio and membrane tension regulate the flat-to-curved transition of the clathrin coat during endocytosis. Nat Commun. 9(1):1109.
Stanifer ML, Kischnick C, Rippert A, Albrecht D, Boulant S. 2017. Reovirus inhibits interferon production by sequestering IRF3 into viral factories. Sci. Rep. 7(1): 10873.
Senís E, Grimm D, Schröder-Braunstein J, Rabin RL, Boulant S. 2017. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut. Front Immunol. 8: 459.
Shah PNM, Stanifer ML, Höhn K, Engel U, Haselmann U, Bartenschlager R, Kräusslich HG, Krijnse-Locker J, Boulant S. 2017. Genome packaging of re-ovirus is mediated by the scaffolding property of the microtubule network. Cell. Microbiol. 19(12): doi: 10.1111/cmi.12765.
Stanifer ML, Rippert A, Kazakov A, Willemsen J, Bucher D, Bender S, Bartenschlager R, Binder M, Boulant S. 2016. Reovirus intermediate subviral particles constitute a strategy to infect intestinal epithelial cells by exploiting TGF-β dependent pro-survival signaling. Cell. Microbiol. 18(12): 1831–1845.
Martínez C, Rodiño-Janeiro BK, Lobo B, Stanifer ML, Klaus B, Granzow M, González-Castro AM, Salvo-Romero E, Alonso-Cotoner C, Pigrau M, Roeth R, Rappold G, Huber W, González-Silos R, Lorenzo J, de Torres I, Azpiroz F, Boulant S, Vicario M, Niesler B, Santos J. 2016. miR-16 and miR-125b are involved in barrier function dysregulation through the modula-tion of claudin-2 and cingulin expression in the jejunum in irritable bowel syndrome with diarrhea. Gut. 66(9):1537-1538.
Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell. 141(4):668-81.
Department of Infectious Deseases, Virology
Medical Faculty
Heidelberg University
Im Neuenheimer Feld 344
69120 Heidelberg